Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asimadoline in Irritable Bowel Syndrome
NCT00454688Phase 2Completed
- Sponsor
- Tioga Pharmaceuticals
- Start
- Aug 2006
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of asimadoline in irritable bowel syndrome (IBS), sponsored by Tioga Pharmaceuticals. Started Aug 2006; status: completed.
02
Drugs
asimadoline
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00454688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454688.